Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06501716 · ClinicalTrials.gov registry record
ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery
A clinical trial, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- 40
- Enrollment target
NCT06501716 is a clinical trial that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 40 participants.
The verdict
NCT06501716 has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
Endonasal endoscopic approaches are an established treatment for suprasellar lesions compromising the optic nerves (ON). Surgery often involves dissecting tumors from the optic nerves and its blood supply, which can result in nerve damage and visual loss after surgery. To date, there are no reliable methods to monitor the optic nerve function during surgery and thus, post-surgical visual outcomes is unknown until the patients are fully awake after surgery for a visual exam. This delay in diagnosis prevents early therapeutic measures and can result in further harm to the ON. We have recently recognized that when ICG is routinely injected during these cases to check for patency of the big arteries the sub millimetric superior hypophyseal arteries supplying (SHA) the ON are also visible and that lack of visualization of these vessels is associated with worse visual deficits after surgery. Thus, ICG may be a tool to intraoperative predict visual outcomes after endonasal approach for suprasellar lesions and fill the nondiagnostic gap. This study will assess whether endoscopic ICG angiography before and after resection of suprasellar lesions can predict post-operative visual deficits. Successful completion will provide surgeons a novel tool to assess visual function during surgery. The ICG endoscopic angiograms suggested in this study are noninvasive and currently routinely performed at the end of surgery to check for patency of big brain arteries.
Interventions
- PROCEDURE Indocyanine Green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-07 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06501716
The ClinicalTrials.gov registry entry for NCT06501716 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indocyanine Green is the first listed.
NCT06501716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06501716 about?
NCT06501716 is a clinical study titled "ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery". Endonasal endoscopic approaches are an established treatment for suprasellar lesions compromising the optic nerves (ON). Surgery often involves dissecting tumors from the optic nerves and its blood supply, which can result in nerve damage and visual loss after surgery. To date, there are no reliable...
What is the current status of trial NCT06501716?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2024-07. Estimated completion is 2025-12.
What interventions are being tested in trial NCT06501716?
The interventions under investigation include: Indocyanine Green (PROCEDURE).
Who is sponsoring clinical trial NCT06501716?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.